- testing |
| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 28 May 2025 | 28 May 2025 |
| Change in Directors | ||
| Board Meeting | 7 May 2025 | 30 Apr 2025 |
| Tata Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2025 inter alia to consider and approve i) Audited Consolidated and Standalone Financial Results of the Company for the quarter and financial year ended March 31 2025 ii) Dividend if any for the year ended March 31 2025 for the approval of the shareholders at the ensuing 86th Annual General Meeting of the Company and iii) Proposal for raising of funds by way of a term loan(s) and/or Non-Convertible Debentures on private placement basis. Outcome of Board Meeting dated May 7, 2025 The Board has recommended a dividend of ? 11 per share i.e. 110% for the financial year 2024-25. The dividend, if approved by the members at the ensuing 86th Annual General Meeting (AGM) of the Company, will be paid (subject to deduction of tax at source) within five days of the AGM Appointment of Secretarial Auditors of the Company Reappointment of Independent Director (As Per BSE Announcement Dated on 07.05.2025) | ||
| Board Meeting | 3 Feb 2025 | 27 Jan 2025 |
| TATA CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 inter alia to consider and approve the Unaudited Consolidated and Audited Standalone Financial Results of the Company for the third quarter and nine months ended December 31 2024. Financial results for the third quarter and nine months ended December 31, 2024 (As Per BSE Announcement Dated on: 03/02/2025) | ||
| Board Meeting | 17 Oct 2024 | 10 Oct 2024 |
| TATA CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2024 inter alia to consider and approve the Unaudited Consolidated and Audited Standalone Financial Results of the Company for the second quarter and half year ended September 30 2024. In accordance with the Tata Code of Conduct for Prevention of Insider Trading pursuant to the amended SEBI (Prohibition of Insider Trading) Regulations 2015 the Company has intimated its Designated Persons regarding the closure of the trading window from Tuesday September 24 2024 to Saturday October 19 2024 (both days inclusive). This is for your information and records. Financial Results for second quarter and half year ended September 30, 2024 Financial Results for the second quarter and half year ended September 30, 2024 (As per BSE Announcement Dated on 17/10/2024) | ||
| Board Meeting | 5 Aug 2024 | 19 Jul 2024 |
| TATA CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2024 inter alia to consider and approve Financial Results of the Company for the quarter ended June 30 2024. Results for the quarter ended June 30, 2024 Unaudited Consolidated and Audited Standalone Financial results for the quarter ended June 30, 2024 (As per BSE Announcement Dated on 05/08/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.